Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinna La Rosa

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Future Virology|January 12, 2013
The immune response to human CMVCorinna La Rosa, Don J Diamond
Transplantation|December 19, 2015
Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant RecipientsAjit P Limaye, Corinna La Rosa, Jeff Longmate, et al.
The Journal of Infectious Diseases|January 31, 2007
Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV diseaseCorinna La Rosa, Ajit P Limaye, Aparna Krishnan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 16, 2011
Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipientsCorinna La Rosa, Ajit P Limaye, Aparna Krishnan, et al.
Virology|May 18, 2010
Intergenic region 3 of modified vaccinia ankara is a functional site for insert gene expression and allows for potent antigen-specific immune responsesEdwin R Manuel, Zhongde Wang, Zhongqi Li, et al.
Immunology Letters|August 19, 2008
A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine modelsAparna Krishnan, Zhongde Wang, Tumul Srivastava, et al.
Journal of Clinical Immunology|April 12, 2005
Reduced type 1 and type 2 cytokines in antiviral memory T helper function among women coinfected with HIV and HCVMaria C Villacres, Oana Literat, Marina Degiacomo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 4, 2006
Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infectionZhongde Wang, Corinna La Rosa, Simon F Lacey, et al.
Experimental Hematology|March 30, 2006
In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia AnkaraCorinna La Rosa, Zhongde Wang, Simon F Lacey, et al.
Vaccine|October 20, 2006
Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1Zhongde Wang, Corinna La Rosa, Zhongqi Li, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Future Virology|January 12, 2013
The immune response to human CMVCorinna La Rosa, Don J Diamond
Transplantation|December 19, 2015
Plasma IL-10 Levels to Guide Antiviral Prophylaxis Prevention of Late-Onset Cytomegalovirus Disease, in High Risk Solid Kidney and Liver Transplant RecipientsAjit P Limaye, Corinna La Rosa, Jeff Longmate, et al.
The Journal of Infectious Diseases|January 31, 2007
Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV diseaseCorinna La Rosa, Ajit P Limaye, Aparna Krishnan, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 16, 2011
Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipientsCorinna La Rosa, Ajit P Limaye, Aparna Krishnan, et al.
Virology|May 18, 2010
Intergenic region 3 of modified vaccinia ankara is a functional site for insert gene expression and allows for potent antigen-specific immune responsesEdwin R Manuel, Zhongde Wang, Zhongqi Li, et al.
Immunology Letters|August 19, 2008
A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine modelsAparna Krishnan, Zhongde Wang, Tumul Srivastava, et al.
Journal of Clinical Immunology|April 12, 2005
Reduced type 1 and type 2 cytokines in antiviral memory T helper function among women coinfected with HIV and HCVMaria C Villacres, Oana Literat, Marina Degiacomo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 4, 2006
Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infectionZhongde Wang, Corinna La Rosa, Simon F Lacey, et al.
Experimental Hematology|March 30, 2006
In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia AnkaraCorinna La Rosa, Zhongde Wang, Simon F Lacey, et al.
Vaccine|October 20, 2006
Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1Zhongde Wang, Corinna La Rosa, Zhongqi Li, et al.
Pageof 5